1. Home
  2. PMCB vs SMX Comparison

PMCB vs SMX Comparison

Compare PMCB & SMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • SMX
  • Stock Information
  • Founded
  • PMCB 1996
  • SMX N/A
  • Country
  • PMCB United States
  • SMX Ireland
  • Employees
  • PMCB N/A
  • SMX N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • SMX Industrial Machinery/Components
  • Sector
  • PMCB Health Care
  • SMX Technology
  • Exchange
  • PMCB Nasdaq
  • SMX Nasdaq
  • Market Cap
  • PMCB 6.6M
  • SMX 6.7M
  • IPO Year
  • PMCB N/A
  • SMX N/A
  • Fundamental
  • Price
  • PMCB $0.93
  • SMX $1.39
  • Analyst Decision
  • PMCB
  • SMX
  • Analyst Count
  • PMCB 0
  • SMX 0
  • Target Price
  • PMCB N/A
  • SMX N/A
  • AVG Volume (30 Days)
  • PMCB 106.5K
  • SMX 9.0M
  • Earning Date
  • PMCB 09-15-2025
  • SMX 01-01-0001
  • Dividend Yield
  • PMCB N/A
  • SMX N/A
  • EPS Growth
  • PMCB N/A
  • SMX N/A
  • EPS
  • PMCB 0.01
  • SMX N/A
  • Revenue
  • PMCB N/A
  • SMX N/A
  • Revenue This Year
  • PMCB N/A
  • SMX N/A
  • Revenue Next Year
  • PMCB N/A
  • SMX N/A
  • P/E Ratio
  • PMCB $160.47
  • SMX N/A
  • Revenue Growth
  • PMCB N/A
  • SMX N/A
  • 52 Week Low
  • PMCB $0.80
  • SMX $1.10
  • 52 Week High
  • PMCB $2.42
  • SMX $4,437.94
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 44.27
  • SMX 28.10
  • Support Level
  • PMCB $1.00
  • SMX $1.30
  • Resistance Level
  • PMCB $1.08
  • SMX $1.56
  • Average True Range (ATR)
  • PMCB 0.08
  • SMX 0.36
  • MACD
  • PMCB -0.00
  • SMX 0.44
  • Stochastic Oscillator
  • PMCB 2.95
  • SMX 17.65

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About SMX SMX (Security Matters) Public Limited Company

SMX (Security Matters) PLC provides one solution to solve both authentication and track and trace challenges in order to uphold supply chain integrity and provide quality assurance and brand accountability to producers of goods. Its technology works as a track and trace system using a marker, a reader, and an algorithm to identify embedded sub-molecular particles in order to track and trace different components along a production process (or any other marked good along a supply chain) to the end producer.

Share on Social Networks: